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Abstract: 
The present article provides a brief overview of the clinical use of two of the most commonly 
used and effective therapies for Attention Deficit-Hyperactivity Disorder (ADHD) in children: 
stimulant medication treatment and training parents in child behavior management skills. The 
clinical issues involved in the use of each treatment, as well as their limitations, are reviewed, 
along with evidence for their efficacy. It is concluded that ADHD is a developmental disorder of 
attention, impulse control, and regulation of activity level that requires multiple treatment 
methods, which must be applied over long time intervals if they are to produce an impact on the 
outcome of children with ADHD. 
 
Article: 
Attention deficit-hyperactivity disorder has been characterized as comprising developmentally 
inappropriate levels of sustained attention and impulse control, and poor regulation of activity 
level to situational demands (American Psychiatric Association, 1987). Others have also included deficits in 
rule- governed behavior, or the ability of language and rules to regulate social conduct, as another 
aspect of this disorder (Barkley, 1981). The disorder is believed to arise in early childhood, with a mean 
age of onset of 4 years (Barkley, Fischer, Newby, & Breen, 1988), and is viewed as being relatively chronic 
throughout childhood and adolescence (Weiss & Hecht- man, 1986). The disorder is frequently 
associated with other co-morbid conditions, such as learning disabilities, oppositional-defiant 
disorder, conduct disorder, academic underachievement, and social skill deficits (Barkley, 1989). 
 
The large number of symptoms associated with ADHD, as well as the numerous other diagnoses 
and deficits seen to coexist with it, requires that treatment be multidisciplinary as well as 
multimodal in nature. A variety of treatments has been attempted with ADHD over the past 
century—far too numerous to review here. However, those treatments with some proven 
effectiveness at symptom reduction include (a) psychopharmacological therapy, (b) direct 
application of behavior therapy techniques in the classroom, (c) parent training in behavior 
management skills, (d) cognitive-behavioral training, and (e) an assorted combination of these 
treatments. No treatment has yet proven to cure this condition — all provide purely symptomatic 
relief. Moreover, no treatment has produced any enduring effects with these children once the 
treatment is withdrawn (Barkley, 1989). As a result, many professionals are now moving to the 
view that ADHD is a developmental disability, requiring longterm symptomatic treatment. 
 
In this article we review the two most commonly used and effective therapies for the 
management of ADHD in children: (a) stimulant medication therapy and (b) training parents in 
behavior management skills. In each case, we present clinically useful information on the nature 
of these two treatments as they are used at the ADHD Clinic of our medical center. Space 
precludes an in-depth review of the literature related to these two treatments, but references to 
more detailed reviews are cited throughout for those wishing greater coverage of these topics. 
 
Both treatments have as their goal to create a better fit between the child with ADHD and the 
demands made on that child by the social environment, especially at home and school. In the 
case of stimulant medication, this is achieved by altering those deficits experienced by the child 
in the domains of inattention, impulsivity, and overactivity through manipulation of the 
neurological substrates believed to mediate these neuropsychological functions. With regard to 
parent training, the goal of a "best fit" is achieved through restructuring the types of demands 
that parents make on their children with ADHD so as to be less taxing of the children's 
behavioral handicaps, and through rearranging environmental contingencies known to affect 
children's motivation to increase work performance, rule-governed behavior, and compliance. 
 
Interestingly, current theories of ADHD that suggest it may be a biologically based deficiency in 
sensitivity to reinforcement or other motivational factors (Barkley, 1990; Haenlein & Caul, 
1987) provide a coherent rationale for the use of both treatments. These theories state that 
ADHD is not so much a deficiency in attention as in the child's sensitivity to environmental 
reinforcers that typically motivate children to perform work, to inhibit behavior, and to sustain 
their responses to assigned tasks. The stimulant medications, via their action on the limbic 
system, striatum, and orbital cortex, act to lower the threshold of sensitivity to reinforcement, 
thereby prolonging responding under conditions that previously would have led to behavioral 
extinction (Haenlein & Caul, 1987; Lou, Henriksen, & Bruhn, 1984; Lou, Henriksen, Bruhn, 
Borner, & Nielsen, 1989). In short, by manipulating the behavioral reward system, these 
medications make the children with ADHD more sensitive to reinforcers available in the 
environment and thereby increase their attention span or persistence of responding (effort) to 
environmental events. Parent training, on the other hand, addresses this hypothesized deficiency 
in sensitivity to reward by altering the environmental contingencies such that the magnitude of 
reinforcement available for appropriate behavior is dramatically increased for children with 
ADHD. Combined, both treatments provide a powerful tool for managing the behavioral 
deficiencies of children with ADHD. Clinicians, therefore, require an understanding of both 
approaches. 
 
 
 
PHARMACOTHERAPY 
Psychostimulant medications (e.g., methylphenidate) have been the most extensively studied 
intervention for ADHD and related disruptive behavior disorders. In fact, over 70o of children 
with ADHD taking these medications exhibit behavioral, academic, and attentional im-
provements, according to parent/teacher ratings, laboratory task performance, and/or direct 
observations (Barkley, 1977). Stimulants are not alone in bringing about a favorable treatment 
response; several investigations have demonstrated the efficacy of antidepressant medications 
with this population (see Pliszka, 1987, for a review). The present review will focus exclusively 
on the use of psychostimulants, however, as they are associated with a higher probability of suc-
cess than antidepressants and have a more extensive research literature documenting their 
effectiveness. 
 
The stimulant medications most commonly employed in the treatment of ADHD are displayed in 
Table 1, along with their generic names, tablet sizes, and typical dose ranges. Traditionally, rec-
ommended dosages for stimulant medications have been based on a child's body weight, using a 
milligram-per-kilogram formula (American Academy of Pediatrics, 1987). Alternatively, recent 
dose- response studies indicate that the behavioral effects of methylphenidate (MPH) are highly 
idiosyncratic and are not moderated by differences in body weight (Rapport, DuPaul, & Kelly, 
1989; Rapport et al., 1987). Thus, determining dosage on a milligram-per-kilogram basis may 
result in under- or overdosing light and heavy children, respectively. For this reason, Table 1 
presents recommended dosages in terms of fixed-doses, as they are typically prescribed. 
 
Effects of Stimulant Medication 
The psychostimulants listed in Table 1 enhance the action of certain neurotransmitters (i.e., 
catecholamines) by inducing their release from the presynaptic neuron, blocking their reuptake, 
and/ or inhibiting the actions of monoamine oxidase (Donnelly & Rapport, 1985). Through this 
action at the neurochemical level, psychostimulants appear to stimulate not only the reticular 
activitating system but also the limbic system, striatum, and other related regions of the brain 
(i.e., orbital-frontal lobes) that are presumed to control attention, arousal, and inhibitory 
processes (Barkley, 1977; Evans, Guiltieri, & Hicks, 1986). Further, there is some evidence to 
suggest that the behavioral effects (as outlined below) of stimulants may be caused by their 
lowering of the central nervous system (CNS) threshold for reinforcement and prolonging the 
sensitivity to reinforcement beyond when satiation or habituation would typically occur (see 
Haenlein & Caul, 1987; Stein, 1964). Peak blood levels are obtained between 1 and 2.5 hours 
postingestion (Shaywitz et al., 1982), with optimal therapeutic effects occurring within 2 to 4 
hours and lasting up to 7 hours. These properties vary somewhat across individuals and within 
children over time. 
 
A plethora of empirical evidence indicates that psychostimulant medications significantly 
enhance certain behavioral, cognitive, and academic processes among children with ADHD. For 
example, MPH has been found to improve the performance of children with ADHD on labora-
tory tests of sustained attention (Barkley et al., 1988; Rapport et al., 1987), impulsive-reflective 
responding (Brown & Sleator, 1979; Rapport et al., 1988), short-term recall (Barkley et al., 1988; 
Rapport, Stoner, DuPaul, Birmingham, & Tucker, 1985), and associative learning (Vyse & 
Rapport, 1987). Attesting to the external validity of these findings, MPH-induced enhancements 
of children's on-task and academic accuracy rates in the classroom have also been obtained 
(Douglas, Barr, O'Neill, & Britton, 1986; Pelham, Bender, Caddell, Booth, & Moorer, 1985; 
Rapport et al., 1987; Rapport et al., 1988), along with concomitant reductions in disruptive, out-
ofseat behavior (Werry & Conners, 1979). Further behavioral effects are found with respect to 
increased compliance, independent play, and responsiveness to social interactions with parents, 
teachers, and peers (Barkley, Karlsson, Strzelecki, & Murphy, 1984; Cunningham, Siegel, & 
Offord, 1985). The amount of commands, criticism, punishment, and censure directed at the 
children by adults is often reduced as well. It is not clear, however, whether the child's 
acceptance by his or her peers is enhanced by these behavioral changes. 
 
Despite clinical lore to the contrary, ADHD does not typically remit in adolescence or adulthood 
in the majority of cases (Barkley, Fischer, Edelbrock, & Smallish, 1990; Gittelman, Mannuzza, 
Shenker, & Bonagura, 1985; Weiss & Hechtman, 1986). Recent investigations have 
demonstrated the clinical efficacy of stimulant medications with teenagers (e.g., Klorman, 
Coons, & Borgstedt, 1987) and adults (Wender, 1987) who have residual ADHD 
symptomatology. Thus, this treatment may be utilized on a chronic basis, as needed, throughout 
the early years of an individual with ADHD. 
 
Side Effects 
Despite the recent controversy in the media regarding severe side effects associated with 
psychostimulants (e.g., Bacon, 1988), side effects are typically quite mild relative to other 
classes of medications. The most frequent side effects are decreased appetite and insomnia, with 
a minority of cases reporting somatic symptoms (e.g., headaches or stomachaches), increased 
tension, growth inhibition, and increases in heart rate or blood pressure. In general, the frequency 
and severity of treatment-emergent effects are apparently dose-related and may diminish with 
reductions in dosage and/or passage of time (Barkley, 1981). In very rare cases, symptoms of 
Tourette's Disorder may be evident following treatment with stimulant medication (Golden, 
1974; Lowe, Cohen, Detlor, Kremenitzer, & Shaywitz, 1982). Although the research evidence 
documenting the validity of this latter side effect is equivocal, caution must be applied when 
considering the use of these drugs among patients with a personal or family history of motor 
and/or vocal tics (Comings & Comings, 1984; Golden, 1982). 
 
An additional complaint that is occasionally associated with MPH is a marked deterioration in 
behavior (e.g., increased irritability and noncompliance), occurring in the late afternoon or early 
evening, following daytime medication administration. This "rebound effect," as it is sometimes 
referred to, may involve a worsening of behavioral control beyond levels observed when the 
child is not taking MPH. While this phenomenon has not been closely studied, a recent inves-
tigation found that only about one third of a large sample of boys treated with several doses of 
MPH exhibited behavioral rebound effects, but not to the extent that a modification of their 
medication status was necessary (Johnston, Pelham, Hoza, & Sturges, 1988). Nevertheless, there 
are case reports of children experiencing emotional sensitivity, weepiness, and irritability either 
during the course of active medication or during this "washout" period, which needs to be kept in 
mind in the clinical use of these medications (Barkley, 1977). 
 
Assessment of Medication Effects 
Although stimulant medications have been found to significantly enhance behavioral and 
academic functioning among groups of children with ADHD, their effects on the behavior of 
individual children are idiosyncratic and dependent upon several factors, including (a) the 
specific task or activity under investigation and (b) the dosage (Rapport et al., 1987; Rapport et 
al., 1988; Sprague & Sleator, 1977). Thus, treatment evaluation must involve the use of multiple 
measures collected across several doses of medication. 
 
Under ideal circumstances, assessment of medication response would take place in the context of 
a double-blind, placebo- controlled trial (see Barkley et al., 1988, or Rapport, 1987, for a more 
detailed discussion). For example, Rapport et al. (1987) evaluated the individual responses of 42 
children with ADHD to several doses (i.e., placebo, 5 mg, 10 mg, 15 mg, and 20 mg) of MPH, 
which were administered in random sequence. Multiple measures of attention were taken across 
clinic and classroom settings, including performance on a continuous performance test (Rosvold, 
Mirsky, Sarason, Bransome, & Beck, 1956), teacher ratings on the Attention factor of the ADD-
H Comprehensive Teacher Rating Scale (ACTeRS) (Ullmann, Sleator, & Sprague, 1984), direct 
observations of classroom on-task behavior, and efficiency on written academic work (i.e., 
percentage of work completed correctly or academic efficiency score). 
 
Consistent with the findings of prior investigations, linear dose-response effects on most 
measures were obtained at the group level, with optimal functioning occurring at the highest 
dose. Alternatively, dose-response effects at the individual level were characterized by 
significant intersubject variability (see Figure 1). The MPH response of individual children could 
be categorized as (a) linear (S-1 and S-2), (b) subject to a threshold effect at a moderate (S-3) or 
high (S-4) dose, (c) representing an inverted U-shape function (S-5), or (d) inconsistent across 
doses (S-6). These patterns were found to be independent of a child's body weight and to vary 
somewhat across specific measures. 
 
In addition to clinic- and classroom- based measures of attention, the research literature has 
demonstrated the dose- response sensitivity of parent/teacher ratings of self-control and 
impulsivity, direct measures of associative learning (Vyse & Rapport, 1987) and impulsivity 
(Brown & Sleator, 1979), and ratings of the frequency and severity of side effects (Barkley et al., 
1988). It is especially important to obtain ratings of side effects from multiple sources (e.g., 
parent, teacher, child) during both medication and nonmedication conditions as complaints of 
apparent "side effects" may occur during placebo conditions as well (Barkley, McMurray, 
Edelbrock, & Robbins, 1989). 
 
Limitations of Pharmacotherapy 
There are several factors that limit the utility and/or efficacy of the treatment of ADHD with 
stimulant medication. First, it must be closely prescribed, titrated, monitored, and withdrawn 
under a physician's care. Thus, in rural areas where such medical care is scarce, pharmacotherapy 
may be unavailable. Second, the results of several long-term follow- up studies investigating 
stimulant medication effects have indicated minimal improvements beyond those obtained at the 
onset of treatment (e.g., Hechtman, Weiss, & Perlman, 1984). However, these results may be due 
to methodological shortcomings (e.g., poor outcome measures, inconsistent dosage titration 
procedures), low compliance with medication administration (e.g., Brown, Borden, Wynne, 
Spunt, & Clingerman, 1987; Firestone, 1982), and/or lack of effects on behavior in situations that 
occur when the drug is inactive. Finally, psychostimulants may be ineffective or inappropriate in 
treating certain subgroups of children with ADHD (e.g., those with anxiety symptoms), some be-
havioral classes (e.g., aggression), or behavior in certain settings. 
 
Summary 
Psychostimulant treatment of children with ADHD has been reliably associated 
 
 
 
with significant short-term enhancement of sustained attention, self-control, interpersonal 
behavior, and academic performance. The dose-response effects of this class of medication are 
subject to individual differences and are task-specific. This indicates the need for a multimethod 
assessment protocol, wherein information regarding a child's response is gathered across settings, 
doses, and behavioral domains. Treatment emergent effects should be monitored during both 
medication and nonmedication conditions. An exclusive reliance upon pharmacotherapy as a 
treatment for ADHD is not recommended, given the complex nature of the disorder and the 
limited long-term efficacy of stimulant medications. Rather, psychostimulants should be a 
critical component of a multimodal intervention program that includes parent training, 
educational modifications, and classroom contingency management procedures. 
 
PARENT TRAINING IN CHILD BEHAVIOR MANAGEMENT SKILLS 
Recent research findings have led many scientists and practitioners to the conclusion that ADHD 
is in large part a biologically based temperamental style (Anastopoulos & Barkley, 1988; 
Wender, 1987) that predisposes youngsters to be inattentive, impulsive, and physically restless, 
as well as deficient in their capacity for rule-governed behavior (Barkley, 1985). Implicit in this 
conceptualization is the need to restructure environmental demands and contingencies so as to 
create a "prosthetic" home and school environment that allows the youngster with ADHD to 
develop compensatory skills for coping with this chronic and pervasive behavioral disability. 
This is by no means an easy task, nor is it one that lends itself to singular treatment approaches. 
Instead, clinical management of ADHD typically requires multimodal therapeutic intervention. 
 
Stimulant medication therapy, described above, is one of the more commonly employed 
treatments in the management of ADHD. So, too, are various modifications within the school 
setting, such as contingency management programming in the classroom, use of daily report card 
systems, and/or special education services. Home-based behavioral intervention is often another 
major component of the overall treatment package. 
 
Many variations of these home-based behavioral interventions have been reported in the 
literature (Barkley, 1981; Dubey, O'Leary, & Kaufman, 1983; Pisterman, McGrath, Firestone, & 
Goodman, 1987). At the University of Massachusetts Medical Center, the ADHD Clinic staff 
routinely employs a variation of the comprehensive parent training program developed by 
Barkley (1981, 1987). Although it bears a resemblance 
to previously reported therapeutic regimens (Forehand & McMahon, 1981; Hanf, 1969; 
Patterson, 1975), this particular parent training program is unique in the way it is tailored to meet 
the special needs of children with ADHD and their families. A brief description of this program 
is provided in the sections that follow. 
 
Historical Background 
The training program for parents of children with ADHD described by Barkley (1981, 1987) 
stems from several theoretical and empirical roots. Among these are Hanfs (1969) two-stage 
program for childhood noncompliance, which Forehand and others have repeatedly employed 
successfully with youngsters manifesting oppositional tendencies, aggressiveness, and conduct 
problems (Forehand & McMahon, 1981; Wells & Forehand, 1985). This program trains parents 
in the skills needed to use differential attention to appropriate versus inappropriate behavior, and 
to use a time-out procedure. The influence of Bell's theoretical notions of bidirectional parent- 
child interactions (Bell & Harper, 1977) is also apparent. In a similar context, Patterson's 
theoretical views on coercive parent-child interactions (Patterson, 1976) are contained in the 
Barkley program. 
 
Finally, what makes the ADHD parent training program most distinct is the degree to which it is 
designed around theoretically and empirically derived notions of ADHD. As noted above, an 
especially prominent premise, interwoven throughout the program, is that ADHD is in most 
cases a biologically based temperamental style that predisposes youngsters to be inattentive, 
impulsive, and physically restless, as well as deficient in their capacity for rule-governed 
behavior. Thus, the main therapeutic objective for children with ADHD and their parents is not 
to cure or eliminate their ADHD problem, but to learn methods of coping with and compensating 
for this ongoing learning and behavioral disability. 
 
The ADHD Parent Training Program 
General Considerations. Generally speaking, parent training services are delivered over the 
course of 6 to 12 therapy sessions in either an individual family or multifamily group format. In 
the ADHD Clinic, most parent training is conducted in a multifamily group format over 9 to 10 
sessions. Prior to discussing the specific steps and techniques of this training program, it is first 
necessary to consider how families are selected for participation. 
 
An important initial screening condition is the age of the identified child. In most cases identified 
children must be between 2 and 11 years of age in order for their parents to be considered for 
enrollment in the program. 
 
Accurate diagnostic assessment of the identified youngster and his or her family also comes into 
play. In the ADHD Clinic, identified children and their families initially undergo a multimethod 
diagnostic evaluation (Barkley, 1987). A clear- cut diagnosis of ADHD, with or without related 
behavioral disturbances such as Oppositional-Defiant Disorder, does not automatically lead to 
the initiation of parent training services, however. Other conditions, such as severe language de-
lays, mental delays, or depression with suicidal ideation, must be ruled out. Provided that there 
are no other major medical or psychosocial complications in the family, referral is made to the 
parent training program. Should certain psychosocial problems, such as serious marital strain, 
preclude parental participation, referrals are directed instead to appropriate mental health 
professionals to begin addressing such complications. As these problems come under better con-
trol, it then becomes possible for the parents to participate in the parent training program. 
 
The severity of the child's behavioral difficulties can also affect when the parent training services 
will be delivered. In cases where the ADHD is extremely severe, it is often initially necessary to 
consider placing the youngster on a stimulant medication, such as Ritalin. To determine whether 
this type of intervention might benefit the child in the absence of any significant side effects, a 
double-blind, drug-placebo trial is usually conducted (Barkley et al., 1988). To avoid 
confounding the outcome of such therapeutic trials, participation in the parent training program 
is postponed until after it has been determined whether the child is likely to continue receiving 
stimulant medication therapy. 
 
Once it has been determined that the parents of a child with ADHD are appropriate for the 
training program, a decision must be made as to whether they would be better suited to receive 
such therapeutic instruction in the context of a multifamily group format or on an individual-
family basis. Because there is relatively little empirical basis for arguing in favor of one format 
over the other, this decision is based largely on the preferences of the parents, as well as on the 
clinical judgment of the therapist. 
 
Although it is not necessarily a major factor in the selection process, another practical question 
that may arise at this time is whether one or both parents need to attend the sessions. Ideally, the 
presence of both parents is desirable, but this, of course, is not always feasible. Because the 
understanding, cooperation, and support of the absent parent is necessary for therapeutic gains to 
be made, the parent in attendance is strongly encouraged to audiotape the session or take detailed 
session notes, which then may be shared with the absent parent at home. 
 
In addition to the above selection criteria, it is extremely useful to consider a number of general 
clinical and stylistic considerations that pertain to all facets of the parent training program. First, 
it is important to recognize that, while there are treatment outlines (Barkley, 1981) and manuals 
(Barkley, 1987) available to assist clinicians in their efforts to employ the ADHD parent training 
program, this is by no means a simple program that can be implemented in a cookbook-recipe 
fashion. On the contrary, it is a therapeutic regimen that requires certain minimum levels of 
clinical expertise. For example, clinicians using this program should be relatively well versed in 
current ADHD research findings, so as to address concerns, such as the Ritalin controversy, that 
may arise from parents who learn about ADHD through the media. Because the ADHD parent 
training program is fundamentally behavioral in nature, expertise in the use of various child 
behavior therapy strategies, especially contingency management techniques, is also highly 
desirable. 
 
Being behavioral in nature, the ADHD parent training program utilizes specific between-session 
assignments to increase parental skill in using acquired therapeutic strategies. At the start of 
every session, time is set aside for reviewing parents' efforts to practice such techniques at home. 
Refinements in their application of these strategies are made, as necessary. When the clinician 
begins to sense that parents have acquired a certain level of mastery, therapeutic attention is 
shifted to the next step of the program. 
 
Implicit in the above discussion is that successful implementation of the parent training program 
requires close collaboration and cooperation between parents and therapists. To this end, it is 
important for clinicians to convey to parents a sense of genuine understanding, caring, and 
support. Also, a Socratic style of conveying concepts and techniques is generally used 
throughout all sessions. Collaboration and cooperation between parents and therapists can be 
facilitated as well by presenting therapeutic information in ways that are easy to understand and 
assimilate. In this regard it is important for therapists to avoid using professional jargon that has 
very little contextual meaning for most parents. Likewise, such information should be discussed 
as much as possible in the context of commonly encountered, daily childcare situations. Given 
that parenting youngsters with ADHD can be a very trying and stressful experience, it is some-
times helpful to incorporate humor into the sessions. Clinicians may also find it beneficial to 
include modeling and visual aids as part of their ongoing therapeutic discussions. For similar 
reasons, written handouts may be distributed to parents at the end of sessions to serve as re-
minders of the steps involved in carrying out a particular between-session assignment. 
 
Although most parents adhere fairly closely to the prescribed therapeutic program, some do not. 
When missed sessions or parental noncompliance are due to unexpected illnesses, family crises, 
or schedule changes, it generally suffices to schdule makeup sessions and/or to remind parents of 
the important connection between their adherence to the regimen and their desired therapeutic 
goals. When these sorts of complications be come more regular, it may be necessary to examine 
whether parent training efforts should be postponed temporarily, until such circumstances have 
been resolved. 
 
Specific Training Steps. As was noted earlier, the ADHD parent training program does not 
confine therapists to a specific number of treatment sessions that must be followed inflexibly. 
Instead, it allows therapists to guide parents through training in a step-by-step fashion, taking as 
many sessions as is necessary to bring about parental mastery of targeted behavior management 
skills. With this in mind, it is now possible to begin discussing the 10 steps that make up this 
intervention program. Readers interested in obtaining a more detailed account of these 
therapeutic procedures should consider reviewing the original sources (Barkley, 1981, 1987) on 
which the following discussion is based. 
 
Step 1— Program Orientation and Review of ADHD. The main purpose of this step is to 
acquaint parents with the mechanics of the treatment program, and to begin the process of 
increasing their knowledge of ADHD. Thus, most of the session is focused on a detailed discus-
sion of the topic of ADHD, often accompanied by a specifically prepared slide presentation, 
which provides parents with an ongoing visual aid that generally facilitates their attention to and 
comprehension of the information being presented. Often covered in this presentation are the 
following topics: the history of this disorder, its primary symptoms, the currently accepted 
clinical criteria used to formulate its diagnosis, its prevalence rates in both clinical and general 
populations, various child and family characteristics, the causes of this disorder, and proven and 
disproven treatment approaches. 
 
Step 2— Understanding Parent-Child Relations and Principles of Behavior Management. After 
reviewing carryover concerns from the previous session on ADHD, the therapist provides 
parents with a conceptual framework for understanding deviant parent-child interactions and 
their therapeutic management. Initially, the theoretical views of Bell (Bell & Harper, 1977) and 
Patterson (1976) are introduced in general terms. Parents are alerted to four major factors that, in 
various combinations, can contribute to the emergence and/or maintenance of children's behavior 
difficulties. This includes a discussion of various child characteristics, parent characteristics, 
family stresses, and situational consequences. 
 
The therapist also describes in greater detail how situational consequences affect the emergence, 
maintenance, and/or exacerbation of children's behavioral difficulties. He or she gives parents an 
overview of general behavioral management principles, as well as guidelines as to how the 
management needs of children with ADHD are different from those of other children. For 
example, because youngsters with ADHD become bored easily and quickly, it is essential for 
parents to recognize that they must use consequences that are salient and meaningful, and that 
they must change such consequences periodically, to keep them interesting and motivating. 
 
Step 3—Enhancing Parental Attending Skills. In this session the therapist emphasizes the 
importance of attending positively to children. In particular, the therapist introduces the notion of 
"special time." Unlike other types of special time that simply involve setting aside time with the 
youngster, the special time under consideration here is one characterized by the requirement that 
parents must remain as nondirective and noncorrective as possible. At the same time they must 
observe and describe their youngster's ongoing play activities in positive terms, while 
simultaneously ignoring any mildly inappropriate behavior that might arise. 
 
Those who have ever tried to employ this sort of special time are well aware of how difficult it 
is. Nevertheless, when implemented properly, it is a procedure that frequently leads to improved 
parental attending skills, as well as to more pleasant parent-child relations. 
 
Step 4—Paying Positive Attention to Appropriate Independent Play and Compliance. After 
reviewing parental efforts to employ special time, the therapist begins expanding the parents' use 
of positive attending skills to other domains. One such domain pertains to the tendency of many 
children, especially those with ADHD, to become disruptive when parents are engaged in some 
home activity, such as talking on the telephone. Another domain that positive attending skills 
may be applied to is when parents issue commands that typically lead to compliance (which 
previously was inadvertently ignored). 
 
Also covered in this session is the manner in which commands are given. Several suggestions are 
made for modifying both the verbal and nonverbal parameters of how parents communicate 
commands, thereby increasing their effectiveness in eliciting compliance. 
 
Step 5—Establishing a Home Token System. Following review and refinement of the therapeutic 
skills that were practiced from the previous session, the therapist embarks upon a discussion of 
one of the more difficult aspects of the training program: setting up a home token system. Such a 
system is utilized for the simple reason that positive attending and ignoring strategies are often 
insufficient for managing children with ADHD. In this phase of the program, rewards are used 
exclusively for compliance with initial parental requests. Use of penalty strategies is deferred 
until the next session. 
 
Step 6— Using Response Cost and Time Out From Reinforcement. After reviewing home use of 
the reward-oriented token system, the therapist introduces the notion of response cost, which 
represents the first time in the training program that a penalty or punishment approach is con-
sidered. More specifically, the therapist instructs parents to begin deducting tokens for 
noncompliance with requests and/or violation of household rules. 
 
Along with advising parents to handle noncompliance by means of response cost, the therapist 
introduces parents to the use of time out from reinforcement, or simply, time out. Although most 
types of noncompliance will continue to be handled via response cost, the therapist encourages 
parents to identify one or two particularly troublesome sources of noncompliance that will be 
addressed by means of time out. 
 
Step 7—Extending Time Out to Other Misbehaviors. Initially, the therapist reviews parental 
efforts to incorporate response cost and time out strategies into the ongoing home token system. 
Given the complexities of implementing time out, most of this session is centered around a 
detailed analysis and refinement of parental efforts to employ this technique at home. Provided 
that this has gone fairly well, and provided that parents feel comfortable with its use, the 
therapist encourages them to begin using time out for two or three other types of noncompliance 
and/or rule violations. 
 
Step 8—Managing Children's Behavior in Public Places. Assuming that parents to this point 
have demonstrated a satisfactory level of expertise in using home- based strategies, the therapist 
instructs them in how to begin generalizing these skills to problematic settings outside the home. 
Among the many problematic outside settings often identified by parents are grocery stores, 
department stores, movie theaters, restaurants, and churches. In addition to learning modified 
contingency management techniques for use in public, parents learn how to avoid many difficult 
situations by reviewing rules and consequences with their children before entering the 
problematic public situation. 
 
Step 9—Handling Future Behavior Problems. After reviewing and fine- tuning parental efforts to 
employ newly acquired management skills in public places, the therapist takes some time to 
review all previously covered aspects of the training program. As needed, the therapist makes 
necessary suggestions for increasing parental effectiveness in using any given procedure. Finally, 
the therapist reviews with parents various ways to handle problems that they believe might arise 
in the future. 
 
Step 10—Booster Session. Although any length of time may be deemed acceptable, it is 
customary for the ADHD Clinic staff to meet with parents for a booster session approximately 1 
month after conducting Step 9. During this session the therapist generally readministers pertinent 
rating scales and questionnaires, which serve as indices of any posttreatment changes that may 
have occurred. Further review and refinement of previously learned intervention strategies is 
conducted as well. Also established at this time is a mutually agreed-upon clinical disposition. If 
desired, this may include scheduling of additional booster sessions. 
 
Research Findings 
Despite its widespread visibility and use as a therapeutic tool, the ADHD parent training 
program has not yet received comprehensive empirical assessment of its efficacy. In well-
controlled evaluations of the clinical effectiveness of this program in its entirety, however, 
preliminary support has been obtained. In a study involving 50 preschool children with ADHD 
and their families, use of this training program led to increased child compliance, which seemed 
to be mediated by several improvements in observed parenting skills (Pisterman et al., 1987). In 
a second study, using three single-case designs, significant improvement in parent ratings of 
home behavior, as well as direct observations of mother- child interactions, resulted from 
training parents in these skills (Pollard, Ward, & Barkley, 1983). 
 
Apart from the limited availability of studies that have directly examined the efficacy of this 
particular combination and sequence of child management skills, a substantial body of research 
exists pertaining to the various techniques that serve as a foundation for this training program. 
Findings obtained from such investigations clearly substantiate its immediate efficacy in 
managing noncompliance in clinic-referred children, its generality across behavior, and its long-
term effectiveness (Baum & Forehand, 1981; Eyberg & Robinson, 1982; Forehand & McMahon, 
1981; Forehand, Rogers, McMahon, Wells, & Griest, 1981; Forehand, Wells, & Griest, 1980; 
Webster-Stratton, 1984). 
 
CONCLUSION 
The treatment of ADHD requires expertise in many different treatment modalities, no single one 
of which can address all of the difficulties likely to be experienced by children with this disorder. 
Among the available treatments, stimulant medication and parent training in child management 
skills remain the most popular and effective approaches for providing relief of these symptoms 
and for preparing parents to cope with this developmental disorder. Classroom management 
procedures, as well as training in anger control, self-control, and social skills, are adjunctive 
procedures with some effectiveness. Regardless of which type is employed, treatments must be 
maintained over longer time intervals than has heretofore been the case, if greater impact is to be 
made on the longterm outcome of children with ADHD. 
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